Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment

Fig. 5

Effects of cancer-derived sEVs on immune cells and therapeutic strategies for cancer treatment by immunotherapy. Cancer-derived sEVs contain immunosuppressive and immunostimulatory molecules, which can be used to activate immune cells. Loading immune drugs into sEVs or inhibition of cancer-derived sEV secretion are two other strategies for immunotherapy

Back to article page